← FDA DRUG APPROVALS

FDA ANDA · ANDA084214

PROMETHAZINE HYDROCHLORIDE

Sponsor: IMPAX LABS

APPLICATION
ANDA084214
TYPE
ANDA
ORIGINAL APPROVAL
1974-08-14
LATEST ACTION
2001-01-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PROMETHAZINE HYDROCHLORIDEDiscontinued
PROMETHAZINE HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

2001-01-23Labeling · Supplement 28AP
1997-03-27Labeling · Supplement 32AP
1997-03-27Labeling · Supplement 33AP
1996-05-30Labeling · Supplement 30AP
1991-08-16Labeling · Supplement 29AP
1974-08-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →